{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:02:57Z","timestamp":1790287377999,"version":"4.1.0"},"reference-count":155,"publisher":"BMJ","issue":"Suppl 2","funder":[{"DOI":"10.13039\/100013986","name":"UK Government","doi-asserted-by":"crossref","award":["UK Aid"],"award-info":[{"award-number":["UK Aid"]}],"id":[{"id":"10.13039\/100013986","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2018,11,6]]},"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>Lassa fever virus (LASV) causes acute viral haemorrhagic fever with symptoms similar to those seen with Ebola virus infections. LASV is endemic to West Africa and is transmitted through contact with excretions of infected <jats:italic>\n                     <jats:italic>Mastomys<\/jats:italic> natalensis<\/jats:italic> rodents and other rodent species. Due to a high fatality rate, lack of treatment options and difficulties with prevention and control, LASV is one of the high-priority pathogens included in the WHO R&amp;D Blueprint. The WHO LASV vaccine strategy relies on availability of effective diagnostic tests. Current diagnostics for LASV include in-house and commercial (primarily research-only) laboratory-based serological and nucleic acid amplification tests. There are two commercially available (for research use only) rapid diagnostic tests (RDTs), and a number of multiplex panels for differential detection of LASV infection from other endemic diseases with similar symptoms have been evaluated. However, a number of diagnostic gaps remain. Lineage detection is a challenge due to the genomic diversity of LASV, as pan-lineage sensitivity for both molecular and immunological detection is necessary for surveillance and outbreak response. While pan-lineage ELISA and RDTs are commercially available (for research use only), validation and external quality assessment (EQA) is needed to confirm detection sensitivity for all known or relevant strains. Variable sensitivity of LASV PCR tests also highlights the need for improved validation and EQA. Given that LASV outbreaks typically occur in low-resource settings, more options for point-of-care testing would be valuable. These requirements should be taken into account in target product profiles for improved LASV diagnostics.<\/jats:p>","DOI":"10.1136\/bmjgh-2018-001116","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T05:40:24Z","timestamp":1549604424000},"page":"e001116","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings"],"prefix":"10.1136","volume":"4","author":[{"given":"Laura T","family":"Mazzola","sequence":"first","affiliation":[{"name":"FIND, Emerging Threats Programme, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Kelly-Cirino","sequence":"additional","affiliation":[{"name":"FIND, Emerging Threats Programme, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"2025072913405949000_4.Suppl_2.e001116.1","unstructured":"CDC , 2017. Lassa fever. Available from: https:\/\/www.cdc.gov\/vhf\/lassa\/index.html [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.2","unstructured":"WHO , 2017. Lassa fever. Available from: http:\/\/www.who.int\/csr\/disease\/lassafever\/en\/ [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.3","unstructured":"WHO , 2017. Lassa fact sheet. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs179\/en\/ [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.4","unstructured":"Nigeria Centre for Disease Control , 2018. Available from: http:\/\/www.ncdc.gov.ng\/diseases\/sitreps\/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.5","unstructured":"WHO , 2018. Lassa fever outbreak news. Available from: http:\/\/www.who.int\/csr\/don\/archive\/disease\/lassa_fever\/en\/ [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.6","unstructured":"WHO , 2017. Lassa Fever \u2013 Nigeria. Available from: http:\/\/www.who.int\/csr\/don\/28-june-2017-lassa-fever-nigeria\/en\/ [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict sierra leone","volume":"8","author":"Shaffer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.8","unstructured":"WHO , 2017. R&D Blueprint for action to prevent epidemics. Available from: http:\/\/www.who.int\/blueprint\/en\/ [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.9","doi-asserted-by":"crossref","unstructured":"Mehand MS , Millett P , Al-Shorbaji F , et al . World Health Organization Methodology to Prioritize Emerging Infectious Diseases in Need of Research and Development. Emerg Infect Dis 2018;24.doi:10.3201\/eid2409.171427","DOI":"10.3201\/eid2409.171427"},{"key":"2025072913405949000_4.Suppl_2.e001116.10","unstructured":"WHO , 2017. Target Product Profiles (TPPs). Available from: http:\/\/www.who.int\/immunization\/research\/ppc-tpp\/target_product_profiles\/en\/ [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.11","first-page":"593","article-title":"Surveillance of Lassa fever in missionaries stationed in West Africa","volume":"52","author":"Frame","year":"1975","journal-title":"Bull World Health Organ"},{"key":"2025072913405949000_4.Suppl_2.e001116.12","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3416857"},{"key":"2025072913405949000_4.Suppl_2.e001116.13","doi-asserted-by":"crossref","unstructured":"Lehmann C , Kochanek M , Abdulla D , et al . Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016. Euro Surveill 2017;22.doi:10.2807\/1560-7917.ES.2017.22.39.17-00088","DOI":"10.2807\/1560-7917.ES.2017.22.39.17-00088"},{"key":"2025072913405949000_4.Suppl_2.e001116.14","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3416857"},{"key":"2025072913405949000_4.Suppl_2.e001116.15","doi-asserted-by":"crossref","unstructured":"Ehlkes L , George M , Samosny G , et al . Management of a Lassa fever outbreak, Rhineland-Palatinate, Germany, 2016. Euro Surveill 2017;22.doi:10.2807\/1560-7917.ES.2017.22.39.16-00728","DOI":"10.2807\/1560-7917.ES.2017.22.39.16-00728"},{"key":"2025072913405949000_4.Suppl_2.e001116.16","doi-asserted-by":"publisher","DOI":"10.3201\/eid0605.000504"},{"key":"2025072913405949000_4.Suppl_2.e001116.17","unstructured":"van Paassen J , Bauer MP , van Dissel JV , et al . Viral haemorrhagic fever in returned travellers; a review on clinical symptoms, management, and outbreak prevention 2010."},{"key":"2025072913405949000_4.Suppl_2.e001116.18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2807\/esm.07.03.00338-en","article-title":"Management of viral haemorrhagic fever in the Netherlands","volume":"7","author":"Swaan","year":"2002","journal-title":"Euro Surveill"},{"key":"2025072913405949000_4.Suppl_2.e001116.19","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw198","article-title":"Imported Case of Lassa Fever in Sweden With Encephalopathy and Sensorineural Hearing Deficit","volume":"3","author":"Grahn","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.20","doi-asserted-by":"publisher","DOI":"10.3201\/eid1610.100774"},{"key":"2025072913405949000_4.Suppl_2.e001116.21","first-page":"894","article-title":"Imported Lassa fever--New Jersey, 2004","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025072913405949000_4.Suppl_2.e001116.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199010183231607"},{"key":"2025072913405949000_4.Suppl_2.e001116.23","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.10.19145-en","article-title":"The first case of Lassa fever imported from Mali to the United Kingdom, February 2009","volume":"14","author":"Atkin","year":"2009","journal-title":"Euro Surveill"},{"key":"2025072913405949000_4.Suppl_2.e001116.24","doi-asserted-by":"crossref","first-page":"19117","DOI":"10.2807\/ese.14.06.19117-en","article-title":"A fatal case of Lassa fever in London, January 2009","volume":"14","author":"Kitching","year":"2009","journal-title":"Euro Surveill"},{"key":"2025072913405949000_4.Suppl_2.e001116.25","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/158.4.872"},{"key":"2025072913405949000_4.Suppl_2.e001116.26","doi-asserted-by":"crossref","unstructured":"Hewson R . Lessons learnt from imported cases and onward transmission of Lassa fever in Europe support broader management of viral haemorrhagic fevers. Euro Surveill 2017;22.doi:10.2807\/1560-7917.ES.2017.22.39.17-00661","DOI":"10.2807\/1560-7917.ES.2017.22.39.17-00661"},{"key":"2025072913405949000_4.Suppl_2.e001116.27","doi-asserted-by":"publisher","DOI":"10.3201\/eid1205.050052"},{"key":"2025072913405949000_4.Suppl_2.e001116.28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(03)13141-8","article-title":"Assessment of travellers who return home ill","volume":"361","author":"Spira","year":"2003","journal-title":"The Lancet"},{"key":"2025072913405949000_4.Suppl_2.e001116.29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/15303660160025912","article-title":"Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals","volume":"1","author":"Demby","year":"2001","journal-title":"Vector-Borne and Zoonotic Diseases"},{"key":"2025072913405949000_4.Suppl_2.e001116.30","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.3.437"},{"key":"2025072913405949000_4.Suppl_2.e001116.31","doi-asserted-by":"publisher","DOI":"10.1126\/science.185.4147.263"},{"key":"2025072913405949000_4.Suppl_2.e001116.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7426.1271"},{"key":"2025072913405949000_4.Suppl_2.e001116.33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13071-017-2146-0","article-title":"No measurable adverse effects of Lassa, Morogoro and Gairo arenaviruses on their rodent reservoir host in natural conditions","volume":"10","author":"Mari\u00ebn","year":"2017","journal-title":"Parasit Vectors"},{"key":"2025072913405949000_4.Suppl_2.e001116.34","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.3.445"},{"key":"2025072913405949000_4.Suppl_2.e001116.35","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/trv047"},{"key":"2025072913405949000_4.Suppl_2.e001116.36","doi-asserted-by":"crossref","DOI":"10.1038\/srep25280","article-title":"New Hosts of The Lassa Virus","volume":"6","author":"Olayemi","year":"2016","journal-title":"Sci Rep"},{"key":"2025072913405949000_4.Suppl_2.e001116.37","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-018-2991-5"},{"key":"2025072913405949000_4.Suppl_2.e001116.38","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.11.3143-3148.1998"},{"key":"2025072913405949000_4.Suppl_2.e001116.39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4102\/ajlm.v5i1.288","article-title":"Molecular confirmation of Lassa fever imported into Ghana","volume":"5","author":"Bonney","year":"2016","journal-title":"Afr J Lab Med"},{"key":"2025072913405949000_4.Suppl_2.e001116.40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7009.857"},{"key":"2025072913405949000_4.Suppl_2.e001116.41","doi-asserted-by":"publisher","DOI":"10.1086\/374853"},{"key":"2025072913405949000_4.Suppl_2.e001116.42","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/tmi.12565","article-title":"Lessons learnt from the management of a case of Lassa fever and follow-up of nosocomial primary contacts in Nigeria during Ebola virus disease outbreak in West Africa","volume":"20","author":"Iroezindu","year":"2015","journal-title":"Trop Med Int Health"},{"key":"2025072913405949000_4.Suppl_2.e001116.43","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM199010183231611","article-title":"Imported Lassa fever-reexamining the algorithms","volume":"323","author":"Johnson","year":"1990","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025072913405949000_4.Suppl_2.e001116.44","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix201"},{"key":"2025072913405949000_4.Suppl_2.e001116.45","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00170-17"},{"key":"2025072913405949000_4.Suppl_2.e001116.46","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/vbz.2018.2276","article-title":"An evaluation of removal trapping to control rodents inside homes in a plague-endemic region of rural northwestern uganda","volume":"18","author":"Eisen","year":"2018","journal-title":"Vector-Borne and Zoonotic Diseases"},{"key":"2025072913405949000_4.Suppl_2.e001116.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2009.07.008"},{"key":"2025072913405949000_4.Suppl_2.e001116.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.05.015"},{"key":"2025072913405949000_4.Suppl_2.e001116.49","doi-asserted-by":"publisher","DOI":"10.3201\/eid1606.100080"},{"key":"2025072913405949000_4.Suppl_2.e001116.50","article-title":"Knowledge of Lassa fever and use of infection prevention and control facilities among health care workers during Lassa fever outbreak in Ondo State, Nigeria","volume":"30","author":"Ijarotimi","year":"2018","journal-title":"Pan Afr Med J"},{"key":"2025072913405949000_4.Suppl_2.e001116.51","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3201\/eid2406.172097","article-title":"Absence of Nosocomial Transmission of Imported Lassa Fever during Use of Standard Barrier Nursing Methods","volume":"24","author":"Grahn","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.52","unstructured":"CDC , 2017. Ebola hemorrhagic fever. Available from: https:\/\/www.cdc.gov\/vhf\/ebola\/index.html [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.53","unstructured":"WHO , 2017. Integrated disease surveillance and response in the African Region. Available from: http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/disease-surveillance-afro\/en\/ [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tmaid.2018.04.016","article-title":"Mitigating the risks of global spread of Lassa fever at the 2018 Hajj pilgrimage","volume":"23","author":"Gautret","year":"2018","journal-title":"Travel Med Infect Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.55","unstructured":"WHO , 2017. Regional Office for Africa. WHO calls for early diagnostic tests for Lassa fever. Available from: http:\/\/www.afro.who.int\/news\/who-calls-early-diagnostic-tests-lassa-fever [accessed 26 Oct 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.56","doi-asserted-by":"crossref","unstructured":"Isere EE , Fatiregun AA , Ilesanmi O , et al . Lessons learnt from epidemiological investigation of Lassa Fever outbreak in a southwest state of Nigeria December 2015 to April 2016. PLoS Curr 2018;10.doi:10.1371\/currents.outbreaks.bc4396a6650d0ed1985d731583bf5ded","DOI":"10.1371\/currents.outbreaks.bc4396a6650d0ed1985d731583bf5ded"},{"key":"2025072913405949000_4.Suppl_2.e001116.57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0300-1652.218414","article-title":"Epidemic preparedness and management: a guide on Lassa fever outbreak preparedness plan","volume":"58","author":"Fatiregun","year":"2017","journal-title":"Niger Med J"},{"key":"2025072913405949000_4.Suppl_2.e001116.58","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-018-0421-8"},{"key":"2025072913405949000_4.Suppl_2.e001116.59","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14787210.2018.1512856","article-title":"Lassa fever outbreaks in Nigeria","volume":"16","author":"Akpede","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025072913405949000_4.Suppl_2.e001116.60","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30179-8","article-title":"Lassa fever and global health security","volume":"18","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2003.04.001"},{"key":"2025072913405949000_4.Suppl_2.e001116.62","first-page":"1","article-title":"Lassa fever in West African sub-region: an overview","volume":"44","author":"Ogbu","year":"2007","journal-title":"J Vector Borne Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.63","doi-asserted-by":"crossref","unstructured":"Asogun DA , Adomeh DI , Ehimuan J , et al . Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis;6:e1839.doi:10.1371\/journal.pntd.0001839","DOI":"10.1371\/journal.pntd.0001839"},{"key":"2025072913405949000_4.Suppl_2.e001116.64","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6648.584"},{"key":"2025072913405949000_4.Suppl_2.e001116.65","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30121-X"},{"key":"2025072913405949000_4.Suppl_2.e001116.66","doi-asserted-by":"publisher","DOI":"10.1086\/322033"},{"key":"2025072913405949000_4.Suppl_2.e001116.67","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(72)90269-6"},{"key":"2025072913405949000_4.Suppl_2.e001116.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.020"},{"key":"2025072913405949000_4.Suppl_2.e001116.69","article-title":"Viral evolution: the history of Lassa virus","volume":"13","author":"Attar","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"2025072913405949000_4.Suppl_2.e001116.70","doi-asserted-by":"publisher","DOI":"10.3201\/eid2104.141469"},{"key":"2025072913405949000_4.Suppl_2.e001116.71","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.01037","article-title":"Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage","volume":"6","author":"Manning","year":"2015","journal-title":"Front Microbiol"},{"key":"2025072913405949000_4.Suppl_2.e001116.72","doi-asserted-by":"publisher","DOI":"10.3201\/eid2403.171905"},{"key":"2025072913405949000_4.Suppl_2.e001116.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.08.012"},{"key":"2025072913405949000_4.Suppl_2.e001116.74","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv522"},{"key":"2025072913405949000_4.Suppl_2.e001116.75","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix406"},{"key":"2025072913405949000_4.Suppl_2.e001116.76","doi-asserted-by":"crossref","DOI":"10.1038\/srep14775","article-title":"The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset","volume":"5","author":"Safronetz","year":"2015","journal-title":"Sci Rep"},{"key":"2025072913405949000_4.Suppl_2.e001116.77","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-4939-6981-4_28","article-title":"Determining the virus life-cycle stage blocked by an antiviral","volume":"1604","author":"Sep\u00falveda","year":"2018","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"2025072913405949000_4.Suppl_2.e001116.78","doi-asserted-by":"publisher","DOI":"10.3201\/eid2409.180233"},{"key":"2025072913405949000_4.Suppl_2.e001116.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2011.02.012"},{"key":"2025072913405949000_4.Suppl_2.e001116.80","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00941-08"},{"key":"2025072913405949000_4.Suppl_2.e001116.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.08.103"},{"key":"2025072913405949000_4.Suppl_2.e001116.82","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01368-06"},{"key":"2025072913405949000_4.Suppl_2.e001116.83","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"7","author":"Robinson","year":"2016","journal-title":"Nat Commun"},{"key":"2025072913405949000_4.Suppl_2.e001116.84","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4396"},{"key":"2025072913405949000_4.Suppl_2.e001116.85","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam7260"},{"key":"2025072913405949000_4.Suppl_2.e001116.86","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1080\/21645515.2017.1306615","article-title":"Vaccines for epidemic infections and the role of CEPI","volume":"13","author":"Plotkin","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"2025072913405949000_4.Suppl_2.e001116.87","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMp1613577","article-title":"New Vaccines against Epidemic Infectious Diseases","volume":"376","author":"R\u00f8ttingen","year":"2017","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025072913405949000_4.Suppl_2.e001116.88","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-7-279","article-title":"Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever","volume":"7","author":"Branco","year":"2010","journal-title":"Virol J"},{"key":"2025072913405949000_4.Suppl_2.e001116.89","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/infdis\/jiy123","article-title":"Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model","volume":"217","author":"Kainulainen","year":"2018","journal-title":"J Infect Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.90","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1080\/21645515.2017.1356500","article-title":"A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever","volume":"13","author":"Cashman","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"2025072913405949000_4.Suppl_2.e001116.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.01.019"},{"key":"2025072913405949000_4.Suppl_2.e001116.92","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890370102"},{"key":"2025072913405949000_4.Suppl_2.e001116.93","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.12.001"},{"key":"2025072913405949000_4.Suppl_2.e001116.94","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.079"},{"key":"2025072913405949000_4.Suppl_2.e001116.95","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1383575"},{"key":"2025072913405949000_4.Suppl_2.e001116.96","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.1.317"},{"key":"2025072913405949000_4.Suppl_2.e001116.97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med"},{"key":"2025072913405949000_4.Suppl_2.e001116.98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003736","article-title":"A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses","volume":"9","author":"Safronetz","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.99","doi-asserted-by":"crossref","unstructured":"Carnec X , Mat\u00e9o M , Page A , et al . A vaccine platform against arenaviruses based on a recombinant hyper-attenuated Mopeia virus expressing heterologous glycoproteins. J Virol 2018;92.doi:10.1128\/JVI.02230-17","DOI":"10.1128\/JVI.02230-17"},{"key":"2025072913405949000_4.Suppl_2.e001116.100","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.22.13934-13942.2005"},{"key":"2025072913405949000_4.Suppl_2.e001116.101","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03035-13"},{"key":"2025072913405949000_4.Suppl_2.e001116.102","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14760584.2016.1184575","article-title":"Vaccine platforms to control Lassa fever","volume":"15","author":"Lukashevich","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"2025072913405949000_4.Suppl_2.e001116.103","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S147276"},{"key":"2025072913405949000_4.Suppl_2.e001116.104","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.4.1753-1755.2004"},{"key":"2025072913405949000_4.Suppl_2.e001116.105","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.15.6992-7004.2000"},{"key":"2025072913405949000_4.Suppl_2.e001116.106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2007.11.019"},{"key":"2025072913405949000_4.Suppl_2.e001116.107","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02351-09"},{"key":"2025072913405949000_4.Suppl_2.e001116.108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-24246-w","article-title":"Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever","volume":"8","author":"Boisen","year":"2018","journal-title":"Sci Rep"},{"key":"2025072913405949000_4.Suppl_2.e001116.109","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/jcm.32.12.2898-2903.1994","article-title":"Early diagnosis of Lassa fever by reverse transcription-PCR","volume":"32","author":"Demby","year":"1994","journal-title":"J Clin Microbiol"},{"key":"2025072913405949000_4.Suppl_2.e001116.110","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/jcm.28.12.2689-2692.1990","article-title":"Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction","volume":"28","author":"Lunkenheimer","year":"1990","journal-title":"J Clin Microbiol"},{"key":"2025072913405949000_4.Suppl_2.e001116.111","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.3.456"},{"key":"2025072913405949000_4.Suppl_2.e001116.112","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000490374","article-title":"Acute Lassa Virus encephalitis with Lassa virus in the cerebrospinal fluid but absent in the blood: a case report with a positive outcome","volume":"10","author":"Okokhere","year":"2018","journal-title":"Case Rep Neurol"},{"key":"2025072913405949000_4.Suppl_2.e001116.113","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-8-478","article-title":"Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection","volume":"8","author":"Branco","year":"2011","journal-title":"Virol J"},{"key":"2025072913405949000_4.Suppl_2.e001116.114","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/infdis\/jix206","article-title":"Moving Lassa fever research and care into the 21st century","volume":"215","author":"Fischer","year":"2017","journal-title":"J Infect Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.115","doi-asserted-by":"publisher","DOI":"10.3390\/v4102031"},{"key":"2025072913405949000_4.Suppl_2.e001116.116","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01948-08"},{"key":"2025072913405949000_4.Suppl_2.e001116.117","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid1606.100040","article-title":"Laboratory diagnosis of Lassa fever, liberia","volume":"16","author":"Panning","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.118","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1993.49.214","article-title":"Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection","volume":"49","author":"Trappier","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"2025072913405949000_4.Suppl_2.e001116.119","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(01)01508-8"},{"key":"2025072913405949000_4.Suppl_2.e001116.120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198601023140104"},{"key":"2025072913405949000_4.Suppl_2.e001116.121","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.138"},{"key":"2025072913405949000_4.Suppl_2.e001116.122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020893","article-title":"Novel arenavirus sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from C\u00f4te d\"Ivoire: implications for evolution of arenaviruses in Africa","volume":"6","author":"Coulibaly-N\"Golo","year":"2011","journal-title":"PLoS One"},{"key":"2025072913405949000_4.Suppl_2.e001116.123","doi-asserted-by":"publisher","DOI":"10.3201\/eid1607.100146"},{"key":"2025072913405949000_4.Suppl_2.e001116.124","doi-asserted-by":"publisher","DOI":"10.1080\/10408360490497456"},{"key":"2025072913405949000_4.Suppl_2.e001116.125","doi-asserted-by":"publisher","DOI":"10.1007\/s004300100061"},{"key":"2025072913405949000_4.Suppl_2.e001116.126","first-page":"631","article-title":"Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections","volume":"57","author":"Wulff","year":"1979","journal-title":"Bull World Health Organ"},{"key":"2025072913405949000_4.Suppl_2.e001116.127","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.12-0466"},{"key":"2025072913405949000_4.Suppl_2.e001116.128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/jcm.20.2.239-244.1984","article-title":"Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay","volume":"20","author":"Niklasson","year":"1984","journal-title":"J Clin Microbiol"},{"key":"2025072913405949000_4.Suppl_2.e001116.129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.08.015"},{"key":"2025072913405949000_4.Suppl_2.e001116.130","doi-asserted-by":"publisher","DOI":"10.3201\/eid2204.151814"},{"key":"2025072913405949000_4.Suppl_2.e001116.131","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.7.2670-2677.2000"},{"key":"2025072913405949000_4.Suppl_2.e001116.132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006361","article-title":"Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G","volume":"12","author":"Gabriel","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.133","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00101-07"},{"key":"2025072913405949000_4.Suppl_2.e001116.134","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv353"},{"key":"2025072913405949000_4.Suppl_2.e001116.135","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw261"},{"key":"2025072913405949000_4.Suppl_2.e001116.136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095635","article-title":"Comprehensive multiplex one-step real-time TaqMan qRT-PCR assays for detection and quantification of hemorrhagic fever viruses","volume":"9","author":"Pang","year":"2014","journal-title":"PLoS One"},{"key":"2025072913405949000_4.Suppl_2.e001116.137","doi-asserted-by":"publisher","DOI":"10.3390\/v1030441"},{"key":"2025072913405949000_4.Suppl_2.e001116.138","doi-asserted-by":"publisher","DOI":"10.3201\/eid1204.051515"},{"key":"2025072913405949000_4.Suppl_2.e001116.139","doi-asserted-by":"publisher","DOI":"10.3201\/eid1301.060837"},{"key":"2025072913405949000_4.Suppl_2.e001116.140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138484","article-title":"A multiplex PCR\/LDR assay for the simultaneous identification of category a infectious pathogens: agents of viral hemorrhagic fever and variola virus","volume":"10","author":"Das","year":"2015","journal-title":"PLoS One"},{"key":"2025072913405949000_4.Suppl_2.e001116.141","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0636"},{"key":"2025072913405949000_4.Suppl_2.e001116.142","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01693-16"},{"key":"2025072913405949000_4.Suppl_2.e001116.143","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-016-0621-4","article-title":"Serosurveillance of viral pathogens circulating in West Africa","volume":"13","author":"O\"Hearn","year":"2016","journal-title":"Virol J"},{"key":"2025072913405949000_4.Suppl_2.e001116.144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003793","article-title":"International external quality assessment study for molecular detection of Lassa virus","volume":"9","author":"Nikisins","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2025072913405949000_4.Suppl_2.e001116.145","unstructured":"WHO , 2017. Accelerating R&D processes. Available from: http:\/\/www.who.int\/blueprint\/what\/research-development\/en\/ [12 Sep 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.146","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2017.02.003"},{"key":"2025072913405949000_4.Suppl_2.e001116.147","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm.4131","article-title":"A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation","volume":"22","author":"Modjarrad","year":"2016","journal-title":"Nat Med"},{"key":"2025072913405949000_4.Suppl_2.e001116.148","unstructured":"WHO , 2018. Lassa Fever Research and Development (R&D) Roadmap. Available from: http:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/LassaFever_Draft_Roadmap_publiccomment_MAY2018.pdf [accessed 24 Sep 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.149","unstructured":"FIND , 2018. FIND pilots partnership-based business model for outbreak response as first investment in new epidemic preparedness strategy. Available from: https:\/\/www.finddx.org\/news\/find-pilots-partnership-based-business-model-outbreak-response-first-investment-new-epidemic-preparedness-strategy\/ [accessed 24 Sep 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.150","unstructured":"FIND , 2018. Target product profiles. Available from: https:\/\/www.finddx.org\/target-product-profiles [accessed 28 Sep 2018]."},{"key":"2025072913405949000_4.Suppl_2.e001116.151","doi-asserted-by":"publisher","DOI":"10.3201\/eid2108.150312"},{"key":"2025072913405949000_4.Suppl_2.e001116.152","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.7.2323-2330.2002"},{"key":"2025072913405949000_4.Suppl_2.e001116.153","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2005.03.018"},{"key":"2025072913405949000_4.Suppl_2.e001116.154","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1348-0421.2010.00286.x","article-title":"Rapid detection of Lassa virus by reverse transcription-loop-mediated isothermal amplification","volume":"55","author":"Fukuma","year":"2011","journal-title":"Microbiol Immunol"},{"key":"2025072913405949000_4.Suppl_2.e001116.155","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00998-12"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2018-001116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:41:19Z","timestamp":1753821679000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2018-001116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":155,"journal-issue":{"issue":"Suppl 2","published-online":{"date-parts":[[2019,2,7]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/bmjgh-2018-001116"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2018-001116","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}